Latest News
HaemAnalytica receives £300,000 investment from the University of Reading
7 Jul 2026
HaemAnalytica has received a £300,000 investment from the University of Reading, where the company was spun out by Prof. Jon Gibbins and Assoc. Prof. Chris Jones. Led by CEO William Kilgallon, COO Gemma Little and CFO Jeremy Rowson, HaemAnalytica is set to revolutionise precision medicine through novel platelet assays.
A new advent of clinical pathway management: an article in PME
7 Jul 2026
Our first PME article explores how measuring platelet function could transform drug discovery, development and clinical trials. PLANA, our platelet function assay, helps select high-efficacy drug assets and de-risk clinical trials through better patient stratification.
Optimising therapy to improve outcomes for heart attack and stroke patients
7 Jul 2026
Our second PME article explores how TRIPLEcheck can personalise treatment for heart attack and stroke patients. Rather than a "one size fits all" approach, testing platelet activity allows patient stratification to optimise treatment, reducing recurrent events and improving outcomes.
HaemAnalytica at London Labs Live
7 Jul 2026
Gemma and Jon recently exhibited at London Labs Live in the start-up zone – a great opportunity to meet other start-ups and see the future of labs in person.